← 返回
未分类 中文

Blockbuster Therapy Predictor

Predict which early-stage biotechnology platforms (PROTAC, mRNA, gene editing, etc.) have the highest potential to become blockbuster therapies. Analyzes cli...
预测早期生物技术平台(PROTAC、mRNA、基因编辑等)成为重磅疗法的潜力,并分析临床及商业化前景。
aipoch-ai aipoch-ai 来源
未分类 clawhub v0.1.0 1 版本 100000 Key: 无需
★ 0
Stars
📥 431
下载
💾 4
安装
1
版本
#latest

概述

Blockbuster Therapy Predictor

Comprehensive analytics tool for forecasting breakthrough therapeutic technologies by integrating multi-dimensional data sources including clinical development pipelines, intellectual property landscapes, and capital market indicators.

Features

  • Multi-Source Data Integration: Aggregates clinical trials, patents, and funding data
  • Predictive Scoring: Calculates Blockbuster Index combining maturity, market potential, and momentum
  • Technology Landscape Mapping: Tracks 10+ emerging therapeutic platforms
  • Investment Intelligence: Provides data-driven R&D and investment recommendations
  • Trend Analysis: Identifies acceleration patterns and inflection points

Usage

Basic Usage

# Run complete analysis with all technologies
python scripts/main.py

# Analyze specific technologies
python scripts/main.py --tech PROTAC,mRNA,CRISPR

# Output in JSON format
python scripts/main.py --output json

Parameters

ParameterTypeDefaultRequiredDescription
-------------------------------------------------
--modestrfullNoAnalysis mode: full or quick
--techstrNoneNoComma-separated list of technologies to analyze
--outputstrconsoleNoOutput format: console or json
--thresholdfloat0NoMinimum blockbuster index threshold (0-100)
--savestrNoneNoSave report to file path

Advanced Usage

# Analyze high-potential technologies only (index ≥70)
python scripts/main.py \
  --threshold 70 \
  --output json \
  --save high_potential_report.json

# Quick analysis of specific platforms
python scripts/main.py \
  --mode quick \
  --tech CAR-T,ADC,Bispecific \
  --output console

Output

Console Output

🏆 BLOCKBUSTER THERAPY PREDICTOR Report
Generated: 2026-02-15 10:30:00
Technologies analyzed: 10

📊 Technology Rankings
Rank  Technology       Blockbuster Index    Maturity    Market Potential    Momentum    Recommendation
🥇 1   mRNA             85.2                 78.5        92.1                88.0        Strongly Recommended
🥈 2   CAR-T            82.3                 85.2        78.5                75.0        Strongly Recommended
🥉 3   CRISPR           79.8                 72.3        88.2                68.0        Recommended

JSON Output Structure

{
  "generated_at": "2026-02-15T10:30:00",
  "total_routes": 10,
  "rankings": [
    {
      "rank": 1,
      "tech_name": "mRNA",
      "blockbuster_index": 85.2,
      "maturity_score": 78.5,
      "market_potential_score": 92.1,
      "momentum_score": 88.0,
      "recommendation": "Strongly Recommended",
      "key_drivers": ["Multiple Phase III trials", "Rapid patent growth"],
      "risk_factors": ["Regulatory uncertainties"],
      "timeline_prediction": "First product expected in 2-4 years"
    }
  ]
}

Scoring Methodology

Blockbuster Index Formula

Blockbuster Index = (Market Potential × 0.5) + (Maturity × 0.3) + (Momentum × 0.2)

Component Scores

ComponentWeightFactors
----------------------------
Market Potential50%Market size, unmet need, competition
Maturity30%Clinical stage, patent depth, funding stage
Momentum20%Patent growth, funding activity, clinical progress

Investment Recommendation Thresholds

Blockbuster IndexRecommendationAction
-------------------------------------------
≥ 80Strongly RecommendedPrioritize R&D investment
60-79RecommendedActive monitoring and early partnerships
40-59WatchMonitor milestones; reassess in 6-12 months
< 40CautiousMinimal investment; consider divestment

Supported Technologies

TechnologyCategoryDescription
-----------------------------------
PROTACProtein DegradationProteolysis Targeting Chimera
mRNANucleic Acid DrugsMessenger RNA therapy platform
CRISPRGene EditingCRISPR-Cas gene editing technology
CAR-TCell TherapyChimeric Antigen Receptor T-cell therapy
BispecificAntibody DrugsBispecific antibody technology
ADCAntibody DrugsAntibody-Drug Conjugate
RNAiNucleic Acid DrugsRNA interference therapy
Gene TherapyGene TherapyAAV vector gene therapy
AllogeneicCell TherapyUniversal/Allogeneic cell therapy
Cell TherapyCell TherapyGeneral cell therapy platform

Technical Difficulty: MEDIUM

⚠️ AI自主验收状态: 需人工检查

This skill requires:

  • Python 3.8+ environment
  • Basic understanding of biotech investment analysis
  • Access to clinical trial, patent, and funding databases (optional)

Dependencies

Required Python Packages

pip install -r requirements.txt

Requirements File

dataclasses
enum

Risk Assessment

Risk IndicatorAssessmentLevel
-----------------------------------
Code ExecutionPython scripts executed locallyMedium
Network AccessNo external API calls in mock modeLow
File System AccessRead/write report files onlyLow
Instruction TamperingStandard prompt guidelinesLow
Data ExposureOutput files saved to workspaceLow

Security Checklist

  • [x] No hardcoded credentials or API keys
  • [x] No unauthorized file system access (../)
  • [x] Output does not expose sensitive information
  • [x] Prompt injection protections in place
  • [x] Input file paths validated (no ../ traversal)
  • [x] Output directory restricted to workspace
  • [x] Script execution in sandboxed environment
  • [x] Error messages sanitized (no stack traces exposed)
  • [x] Dependencies audited

Prerequisites

# Python dependencies
pip install -r requirements.txt

Evaluation Criteria

Success Metrics

  • [ ] Successfully executes main functionality
  • [ ] Output meets quality standards
  • [ ] Handles edge cases gracefully
  • [ ] Performance is acceptable

Test Cases

  1. Basic Functionality: Run without arguments → Expected output with all technologies
  2. Technology Filter: Use --tech flag → Only specified technologies analyzed
  3. JSON Output: Use --output json → Valid JSON format output
  4. Threshold Filter: Use --threshold 70 → Only technologies with index ≥70 shown

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-15
  • Known Issues: None
  • Planned Improvements:
  • Integration with real-time data APIs
  • Additional technology platforms
  • Enhanced visualization capabilities

References

See references/ for:

  • Historical blockbuster case studies
  • Clinical trial data sources
  • Patent analysis methodologies
  • Investment scoring frameworks

Limitations

  • Data Source: Uses mock data for demonstration; real-time data integration required for production use
  • Prediction Accuracy: Model provides indicative scores; not investment advice
  • Technology Coverage: Limited to pre-configured technology platforms
  • Market Dynamics: Cannot predict black swan events or regulatory changes
  • Regional Bias: Data primarily focused on US/EU markets

⚠️ DISCLAIMER: This tool provides quantitative analysis for decision support only. All investment and R&D decisions should incorporate qualitative domain expertise, regulatory consultation, and comprehensive due diligence. Past performance of historical blockbusters does not guarantee future success of emerging technologies.

版本历史

共 1 个版本

  • v0.1.0 当前
    2026-03-30 17:56 安全 安全

安全检测

腾讯云安全 (Keen)

安全,无风险
查看报告

腾讯云安全 (Sanbu)

安全,无风险
查看报告

🔗 相关推荐

data-analysis

Medical Research Literature Reader Pro

aipoch-ai
一种面向临床、生物信息、转化及基础实验背景用户的医学研究原生文献阅读技能。使用此技能……
★ 1 📥 848
productivity

Peer Review Response Drafter

aipoch-ai
协助起草专业的同行评审回复信。当用户提及「审稿人意见」、「回复信」、「同行评审」、「修订再提交」等关键词时触发。
★ 0 📥 852
content-creation

Journal Matchmaker

aipoch-ai
根据摘要内容推荐合适的高影响因子或领域期刊,以便提交稿件;当用户提供论文摘要时触发。
★ 0 📥 838